摘要
目的探讨消异方对子宫内膜异位症患者体内MCP-1和IL-6含量的影响。方法将子宫内膜异位症患者103例随机分为中药治疗组(33例)、安慰剂对照组(36例)和空白对照组(34例),比较三组治疗前后血清和在位内膜中MCP-1、IL-6含量的变化。结果中药治疗组治疗后血清和在位内膜中MCP-1和IL-6含量较用药前明显降低,而空白对照组和安慰剂对照组治疗前后血清和在位内膜中MCP-1和IL-6含量变化不明显。结论消异方能降低子宫内膜异位症患者血清和在位内膜中MCP-1和IL-6含量。
Objectives：To investigate effects of Xiaoyi prescription on changes of contents of MCP-1 and IL-6 in patients with endometriosis（EM patients）.Methods：103 patients with endometriosis were divided into the traditional Chinese medicine treatment group（33 patients）,the placebo control group（36 patients）,and the blank control group（34 patients）.The changes of contents of MCP-1 and IL-6 in blood serum and endometrium were compared between the groups before and after the treatment.Results：There is a significantly reduction in contents of MCP-1 and IL-6 in the blood serum and endometrium in the traditional Chinese medicine group after the treatment,while neither the changes in blood serum and endoumetrium in the blank control group nor those in the placebo control group were as significant as they in the traditional Chinese medicine group.Conclusion：Xiaoyi prescription is able to reduce the contents of MCP-1 and IL-6 in both blood serum and endometrium in patients with endometriosis.
出处
《中国优生与遗传杂志》
2011年第5期113-114,116,共3页
Chinese Journal of Birth Health & Heredity
基金
山东省科技发展计划项目2009GG10002074
